AstraZeneca Korea recertified Innovative Pharma Company
By Whang, byung-woo | translator Alice Kang
25.01.07 05:29:03
가나다라
0
Third consecutive certification extension since being certified as an Innovative Pharmaceutical Company in 2018
Recognized for contributing to the development of the domestic pharmaceutical industry through open innovation strategies
This marks the third consecutive recertification since the company was first certified in 2018, and recognizes the company's steady R&D investments and achievements made through global collaborations.
With the extension, AstraZeneca Korea will be maintaining its status as an Innovative Pharmaceutical Company for another three years, until 2027.
The Innovative Pharmaceutical Company certification system, which is organized by the Ministry of Health and Welfare, is based on the ‘Special Act on Fostering and
Whang, byung-woo(tuai@dailypharm.com)
If you want to see the full article, please JOIN US (click)